You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR CHIRHOSTIM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CHIRHOSTIM

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00587132 ↗	Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma	Terminated	ChiRhoClin, Inc.	Phase 1/Phase 2	2006-11-01	The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.
NCT00587132 ↗	Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma	Terminated	Mayo Clinic	Phase 1/Phase 2	2006-11-01	The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.
NCT01087801 ↗	A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers	Completed	ChiRhoClin, Inc.	Phase 3	2007-10-01	The following are the study hypothesis: - Secretin administration compared to placebo will result in a statistically significantly greater percentage of collected fluid samples being predominantly of exocrine pancreas origin when samples are duodenal aspirates. - Secretin administration compared to placebo will result in a statistically significantly greater percentage of collected fluid samples meeting the minimum specifications for use in the indicated laboratory test of DNA mutational analysis.
NCT01265875 ↗	Secretin Infusion for Pain Due to Chronic Pancreatitis	Completed	Dartmouth-Hitchcock Medical Center	Phase 1/Phase 2	2010-12-01	- To determine if intravenous secretin administration in escalating doses three times daily for three days will improve the pain from CP at the time of infusion, after each infusion (1 to 3 hours), at Day 7 after infusion, and at Day 30 after infusion. - To validate the safety of intravenous secretin administration at the dosage indicated in this study.
NCT01265875 ↗	Secretin Infusion for Pain Due to Chronic Pancreatitis	Completed	ChiRhoClin, Inc.	Phase 1/Phase 2	2010-12-01	- To determine if intravenous secretin administration in escalating doses three times daily for three days will improve the pain from CP at the time of infusion, after each infusion (1 to 3 hours), at Day 7 after infusion, and at Day 30 after infusion. - To validate the safety of intravenous secretin administration at the dosage indicated in this study.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CHIRHOSTIM

Condition Name

Chart
Table

Condition Name for CHIRHOSTIM
Intervention	Trials
Abdominal Pain	1
Chronic Pancreatitis	1
Dyspepsia	1
Healthy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CHIRHOSTIM
Intervention	Trials
Pancreatitis	2
Pancreatitis, Chronic	2
Pancreatic Diseases	1
Irritable Bowel Syndrome	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CHIRHOSTIM

Trials by Country

Map
Table

Trials by Country for CHIRHOSTIM
Location	Trials
United States	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for CHIRHOSTIM
Location	Trials
Minnesota	2
Ohio	1
New Hampshire	1
Missouri	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CHIRHOSTIM

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CHIRHOSTIM
Clinical Trial Phase	Trials
Phase 3	2
Phase 1/Phase 2	3
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CHIRHOSTIM
Clinical Trial Phase	Trials
Completed	4
Not yet recruiting	1
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CHIRHOSTIM

Sponsor Name

Chart
Table

Sponsor Name for CHIRHOSTIM
Sponsor	Trials
ChiRhoClin, Inc.	5
Mayo Clinic	2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CHIRHOSTIM
Sponsor	Trials
Other	6
Industry	5
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.